NCT00705003 · Interventional trial
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
Overall registry status Completed
Phase 2
Conditions Major Depressive Disorder
Delaware Valley sites
- CRI Worldwide · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory